Evaluation of MRSASelect™xs chromogenic medium for the early detection of methicillin-resistant Staphylococcus aureus from blood cultures

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 24, Issue 4, 2013, Pages

  Manickam, Kanchana ^a,b   Walkty, Andrew ^a,b,c   Lagacé Wiens, Philippe R S ^a,b   Adam, Heather ^a,b   Swan, Barbara ^a   McAdam, Brenda ^a,b   Pieroni, Peter ^a   Alfa, Michelle ^a,b   Karlowsky, James A ^a,b  

^a Diagnostic Services of Manitoba Inc   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Blood cultures; Chromogenic agar; MRSA; Staphylococcus aureus

Indexed keywords

ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; CANADA; CHROMOGENIC MEDIUM; CULTURE MEDIUM; EVALUATION STUDY; GRAM STAINING; HUMAN; LABORATORY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HOMINIS; STAPHYLOCOCCUS LUGDUNENSIS; STAPHYLOCOCCUS SCHLEIFERI; STAPHYLOCOCCUS WARNERI; TURNAROUND TIME;

EID: 84892161192     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/201516     Document Type: Article

References (23)

1. Corey GR. Staphylococcus aureus bloodstream infections: Definitions and treatment. Clin Infect Dis 2009; 48:S254-9.
2. Thwaites GE, Edgeworth JD, Gkrania-Klotsas E, et al. Clinical management of Staphylococcus aureus bacteremia. Lancet Infect Dis 2011; 11:208-22.
3. Adam HJ, DeCorby M, Rennie R, Karlowsky JA, Hoban DJ, Zhanel GG. Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: Results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 2011; 69:307-13.
4. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber J, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis 2003; 36:53-9.
5. Kim SH, Park WB, Lee CS, et al. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteremia: Analytical strategy using propensity scores. Clin Microbiol Infect 2006; 12:13-21.
6. Bassetti M, Trecarichi EM, Mesini A, et al. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteremia. Clin Microbiol Infect 2012; 18:862-9.
7. Naber CK. Staphylococcus aureus bacteremia: Epidemiology, pathophysiology, and management strategies. Clin Infect Dis 2009; 48:231-7.
8. Ammerlaan H, Seifert H, Harbarth S, et al. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 western European countries. Clin Infect Dis 2009; 49:997-1005.
9. Khatib R, Saeed S, Sharma M, Riederer K, Fakih MG, Johnson LB. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2006; 25:181-5.
10. Lodise T P, McKinnon PS, Levine D P, Rybak MJ. Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 2007; 51:3731-3.
11. Lodise T P, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36:1418-23.
12. Paul M, Kariv G, Goldberg E, et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteremia. J Antimicrob Chemother 2010; 65:2658-65.
13. Robinson JO, Pearson JC, Christiansen KJ, Coombs GW, Murray RJ. Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: A 10-year retrospective review. Eur J Clin Microbiol Infect Dis 2009; 28:353-61.
14. Schweizer ML, Furuno J P, Harris AD, et al. Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: A retrospective cohort study. PLoS ONE 2010; 5:e11432.
15. Garcia LS, Isenberg HD, eds. Clinical Microbiology Procedures Handbook, 2nd edn. Washington, DC: ASM Press, 2007.
16. Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff DA. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S aureus blood culture test in patients with S aureus bacteremia. Clin Infect Dis 2010; 51:1074-80.
17. Frye AM, Baker CA, Rustvold DL, et al. Clinical impact of a realtime PCR assay for rapid identification of staphylococcal bacteremia. J Clin Microbiol 2012; 50:127-33.
18. Stoakes L, Reyes R, Daniel J, et al. Prospective comparison of a new chromogenic medium, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2006; 44:637-9.
19. Riedel S, Dam L, Stamper PD, Shah SAR, Carroll KC. Evaluation of Bio-Rad MRSASelect agar for detection of methicillin-resistant Staphylococcus aureus directly from blood cultures. J Clin Microbiol 2010; 48:2285-8.
20. Pape J, Wadlin J, Nachamkin I. Use of BBL CHROMagar MRSA medium for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures. J Clin Microbiol 2006; 44:2575-6.
21. Peterson JF, Dionisio AA, Riebe KM, et al. Alternative use for Spectra MRSA chromogenic agar in detection of methicillin-resistant Staphylococcus aureus from positive blood cultures. J Clin Microbiol 2010; 48:2265-7.
22. Cattoir V, Merabet L, Djibo N, et al. Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood cultures. Clin Microbiol Infect 2011; 17:425-31.
23. Kim SH, Park WB, Lee KD, et al. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteremia. J Antimicrob Chemother 2004; 54:489-97.